Original news and analysis on international IP policy
For most people, champagne evokes a sophisticated bubbly white wine, associated with luxury and celebration. Champagne is also a region of France where this particular wine originates. The protection of geographical indications, such as champagne, but also Darjeeling tea or Idaho potatoes, is being discussed in several fora, and next week at the World Intellectual Property Organization.
European Union lawmakers will vote soon on a non-binding measure aimed at protecting genetic resources and fighting biopiracy, or misappropriation. Despite the critical importance of these issues, efforts to draw the European Parliament's attention to the resolution have been difficult and its outcome is less than clear, its author says.
International copyright flexibilities are ill-suited to the need of developing countries to create effective access to printed materials in schools, a new book argues. The author, whose work was presented last week at the World Intellectual Property Organization, urges a normative and institutional rethinking of the current system.
Several countries have established fast-track programmes to expedite the examination of environmentally oriented, or “green,” patents. Preliminary findings from a study assessing the success of those programmes were presented last week to Geneva intellectual property professionals.
Four of the world's most populous nations are in Southeast Asia and with roughly two-thirds of its population lacking access to medicines, the region holds promise for the cheaper generic drugs. Already, observers are taking note of how the region is changing the dynamics of the global business.
Non-governmental organisations this week vehemently voiced their positions at the World Intellectual Property Organization on a text that could become a treaty increasing access to books by visually impaired people. The NGO exercise unveiled a range of stances on what the treaty should and should not do.
Kirtsaeng v. John Wiley & Sons presents the United States Supreme Court with a stark and weighty choice. In the 29 October oral argument [pdf], Supap Kirtsaeng urged the court to uphold purchasers’ right to freely dispose of copyrighted works they have purchased, even when those works are made overseas. If this right is struck down, Kirtsaeng warned, museums in the US may be unable to borrow works of art created overseas, consumers may be unable to sell their used books and CDs, and many companies engaged in secondary markets, such as eBay and used car dealers, may be put out of business.
The recent Internet Governance Forum in Baku, Azerbaijan was used as a stage for some very targeted messages on the upcoming World Conference on International Telecommunication, it saw yet another round of exchanges on some of the tough questions of digital society from privacy and security to future copyright, and had the most intensive discussions on human rights in cyberspace so far.
Richard Elliott writes: Canada’s Access to Medicines Regime (CAMR) was a unanimous pledge by Parliament to help people dying in developing countries because they lack access to affordable medicines. So far, it has delivered only one medicine to one country since Parliament created it more than 8 years ago (in May 2004). CAMR is clearly not working; it needs to be reformed to address the unnecessary deficiencies and limitations that have rendered it cumbersome and user-unfriendly for both developing countries and the manufacturers of lower-cost, generic medicines - the two parties that need to make use of CAMR if patients are to get the medicines they need.
A study compiling the results of two surveys on the need for reform of United Nations development activities was presented this week in the presence of US and Indian ambassadors who agreed on needed improvements, though with a North and South perspective.
In the recent decision on the case “Novartis AG versus Laboratorios LKM SA re cease of use of patent” the Third Chamber of the Federal Civil and Commercial Appellate Court of Argentina set an important precedent in relation to the interpretation of the ius prohibendi of patent holders. In other words, the demarcation of what they can and cannot prohibit.
The European Union’s global plan for health, development cooperation includes the commitment that high-quality medicines and care in the developing world be available without restrictions. As such, despite its growing impact and strong investment in product R&D, the plan seemingly lacks adequate coherence, innovative financing, and coordination, collaboration with concerned parties. Filling these gaps would be a matter of priority and a way for the EU to achieve indisputable field leadership.